Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $494.52 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $214.45 | 4 | $0 (2024) |
| Biogen, Inc. | $199.69 | 2 | $0 (2022) |
| GENZYME CORPORATION | $62.71 | 2 | $0 (2023) |
| Sobi, Inc | $17.67 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $164.90 | 3 | Merck Sharp & Dohme LLC ($164.90) |
| 2023 | $112.26 | 3 | GENZYME CORPORATION ($62.71) |
| 2022 | $199.69 | 2 | Biogen, Inc. ($199.69) |
| 2019 | $17.67 | 1 | Sobi, Inc ($17.67) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $70.83 | General |
| 11/09/2024 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $69.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/01/2024 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/04/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $32.15 | General |
| 09/03/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $30.56 | General |
| 09/02/2023 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/16/2022 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Neurology | ||||||
| 08/08/2022 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $99.69 | General |
| Category: Neurology | ||||||
| 08/08/2019 | Sobi, Inc | Synagis (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Immunology | ||||||
About Dr. Sylvia Arce, M.D
Dr. Sylvia Arce, M.D is a Hospitalist healthcare provider based in Mayaguez, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033178868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sylvia Arce, M.D has received a total of $494.52 in payments from pharmaceutical and medical device companies, with $164.90 received in 2024. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($494.52).
Practice Information
- Specialty Hospitalist
- Other Specialties Neonatal-Perinatal Medicine
- Location Mayaguez, PR
- Active Since 03/21/2006
- Last Updated 01/22/2019
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1033178868
Products in Payments
- SPINRAZA (Biological) $199.69
- VAXNEUVANCE (Biological) $143.62
- Synagis (Drug) $17.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.